EUVIMEDSkopri EUVIMED
Open access

Adipose FGF21 signalling mediates the anti‐senescence effects of protein restriction

Xiaohan Yang iD, Yanni Wu, Yi Yang, Long Huang, Xianyang Jin, Xuemei Jiang, Chao Jin, Bin Feng iD, Lianqiang Che, Shengyu Xu, Yan Lin, Yong Zhuo and 2 more

The Journal of Physiology · 2026-09 · 604 (18) · 7702-7720

DOI: 10.1113/jp291341 ↗

At a glance

Journal article in The Journal of Physiology, published online on 2026-08-28. Written by Xiaohan Yang and 13 co-authors. Institution: Animal Nutrition Institute, Sichuan Agricultural University, Chengdu, China. Major MEDLINE topics: Fibroblast Growth Factors, Adipocytes, Cellular Senescence, Diet, Protein-Restricted. Cited 2 times so far (Crossref); 54 references. The full text is freely available in PubMed Central. Funded by: National Key R&D Program of China, National Natural Science Foundation of China.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Dietary protein restriction (PR) is a well‐recognized nutritional intervention that enhances metabolic health and extends lifespan. However, the mechanisms behind this phenomenon are not well understood. Here, using genetic loss‐of‐function models for fibroblast growth factor 21 ( Fgf21) and its obligate co‐receptor β‐Klotho ( Klb ), we demonstrate that FGF21–KLB signalling in adipocytes is indispensable for the anti‐senescence effects of PR. Specifically, adipocyte FGF21 signalling preserves mitochondrial integrity, maintains an anti‐inflammatory milieu and sustains nicotinamide adenine dinucleotide (NAD + ) homeostasis under PR. Mechanistically, FGF21 enhances adipocyte NAD + abundance through activation of AMP‐activated protein kinase to maintain mitochondrial integrity. Additionally, high‐protein feeding induces adipocyte senescence and metabolic dysfunction could be mitigated by exogenous FGF21 supplementation. Together, these findings establish adipose FGF21 signalling as a pivotal endocrine axis that couples dietary protein availability to adipocyte NAD + metabolism and identify it as a promising target for the prevention and treatment of age‐related metabolic disorders. image Key points Dietary protein restriction improves metabolic health and extends lifespan, but the mechanisms responsible for these benefits are not fully understood. Fibroblast growth factor 21 (FGF21) is a hormone strongly induced by low‐protein diets and has emerged as an important regulator of metabolic adaptation. We show that FGF21 signalling specifically in adipose tissue is essential for the anti‐senescence effects of dietary protein restriction. FGF21 preserves mitochondrial integrity by maintaining nicotinamide adenine dinucleotide metabolism through AMP‐activated protein kinase activation. Targeting the FGF21–adipose tissue pathway may provide new strategies to prevent or treat age‐related metabolic dysfunction.

Subjects

MeSH terms (MEDLINE)

Fibroblast Growth FactorsAdipocytesCellular SenescenceDiet, Protein-RestrictedAdipose TissueAnimalsSignal TransductionKlotho ProteinsNADMiceMembrane Proteins3T3-L1 CellsMitochondriaAMP-Activated Protein KinasesMice, Inbred C57BL

Author keywords

NAD+ homeostasisfibroblast growth factor 21 (FGF21)mitochondrial integrityprotein restrictionwhite adipose tissue (WAT)

Substances

Fibroblast Growth Factorsfibroblast growth factor 21Klotho ProteinsNADKlb protein, mouseMembrane ProteinsAMP-Activated Protein Kinases

Authors and institutions

  • Animal Nutrition Institute, Sichuan Agricultural University, Chengdu, China.
  • Key Laboratory for Animal Disease-Resistant Nutrition of the Ministry of Education of China, Sichuan Agricultural University, Chengdu, China.
  • Animal Nutrition and Efficient Feed Utilization Key Laboratory of Sichuan Province, Sichuan Agricultural University, Chengdu, Sichuan, China.

ORCID profiles: Xiaohan Yang, Bin Feng, Lun Hua

Funding

  • National Key R&D Program of China
  • National Natural Science Foundation of China

Cite

APA

Yang, X., Wu, Y., Yang, Y., Huang, L., Jin, X., Jiang, X., Jin, C., Feng, B., Che, L., Xu, S., Lin, Y., Zhuo, Y., Wu, & Hua, L. (2026). Adipose FGF21 signalling mediates the anti‐senescence effects of protein restriction. The Journal of Physiology, 604(18), 7702-7720. https://doi.org/10.1113/jp291341

Vancouver

Yang X, Wu Y, Yang Y, Huang L, Jin X, Jiang X, et al. Adipose FGF21 signalling mediates the anti‐senescence effects of protein restriction. The Journal of Physiology. 2026;604(18):7702-7720. doi:10.1113/jp291341

BibTeX
@article{Yang2026,
  author = {Yang, Xiaohan and Wu, Yanni and Yang, Yi and Huang, Long and Jin, Xianyang and Jiang, Xuemei and Jin, Chao and Feng, Bin and Che, Lianqiang and Xu, Shengyu and Lin, Yan and Zhuo, Yong and Wu, De and Hua, Lun},
  title = {Adipose FGF21 signalling mediates the anti‐senescence effects of protein restriction},
  journal = {The Journal of Physiology},
  year = {2026},
  volume = {604},
  number = {18},
  pages = {7702--7720},
  doi = {10.1113/jp291341}
}
Start for free →